Evidence map›Paper›PMID 38055106›Full record

ReviewSurgery today2024

Early-onset hepatic veno-occlusive disease after liver transplantation: an institutional experience and analysis of a literature-based cohort.

Yutaka Endo, Masahiro Shinoda, Junki Maehara, Taizo Hibi, Yasushi Hasegawa, Hideaki Obara, Minoru Kitago, Hidenori Ojima, Minoru Tanabe, Yuko Kitagawa

Abstract readReview
PubMed Publisher
In one paragraph

Review in Surgery today, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yutaka EndoDepartment of Surgery, Keio University School of Medicine, Tokyo, Japan.
Masahiro ShinodaDepartment of Surgery, Keio University School of Medicine, Tokyo, Japan. masa02114@yahoo.co.jp.
Junki MaeharaDepartment of Pathology, Keio University School of Medicine, Tokyo, Japan.
Taizo HibiDepartment of Pediatric Surgery and Transplantation, Kumamoto University School of Medicine, Kumamoto, Japan.
Yasushi HasegawaDepartment of Surgery, Keio University School of Medicine, Tokyo, Japan.
Hideaki ObaraDepartment of Surgery, Keio University School of Medicine, Tokyo, Japan.
Minoru KitagoDepartment of Surgery, Keio University School of Medicine, Tokyo, Japan.
Hidenori OjimaDepartment of Pathology, Keio University School of Medicine, Tokyo, Japan.
Minoru TanabeDepartment of Tokyo Medical and Dental University, Graduate School of Medical and Dental Sciences Advanced Therapeutic Sciences, Hepatobiliary and Pancreatic Surgery, Tokyo, Japan.
Yuko KitagawaDepartment of Surgery, Keio University School of Medicine, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeHepatic veno-occlusive disease (HVOD) after liver transplantation (LT) is almost always a fatal complication. We assessed the outcomes of HVOD in a single institute and analyzed a literature-based cohort.

methodsWe reviewed the medical records of recipients of LT performed between 1995 and 2020 at our institute and the literature on HVOD after LT. We then analyzed the clinical features based on a "pooled" cohort of cases identified in our institute and reported in the literature.

resultsHVOD was diagnosed in 3 of 331 LT recipients, all of whom died in hospital, on days 164, 12, and 13, respectively. Our comprehensive review of the literature, as well as our cases, identified eight cases of HVOD that developed within 14 days after LT (early-onset type). Early-onset HVOD had a significantly worse prognosis than HVOD that developed beyond 2 weeks after LT (non-early-onset type), which was identified in 22 cases (25.0% vs. 86.1% of the 3-month graft survival rate). The most common causes of early-onset and non-early-onset types were acute cellular rejection (50%) and drug-induced disease (50%), respectively.

conclusionEarly-onset HVOD developing within 14 days after LT has a poor prognosis.

Indexed as

Hepatic Veno-Occlusive DiseaseLiver TransplantationPostoperative ComplicationsAdultCohort StudiesFemaleGraft RejectionGraft SurvivalHumansMaleMiddle AgedPrognosisSurvival RateTime FactorsHepatic veno-occlusive diseaseLiver transplantationPooled analysisPrognosisSurvival rate

Identifiers

PMID38055106

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.